Skip to Main Content

Paper Details

Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer.
Journal for ImmunoTherapy of Cancer
34
2021
CD47, NF-kB, PrCR, TAMs, TNBC, TNBC cells, TNBC tumors, cabazitaxel, cancer, cancer cells, cancers, human, immune cell population, macrophage, macrophages, mouse, triple-negative breast cancer, tumor, tumor-associated macrophages
Author NameAffiliation
Steven T Rosen
Steven T RosenBeckman Research Institute
  • 1 - 2

Datasets

Release 1.2